Successful Xenograft of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimen from Human Extrahepatic Cholangiocarcinoma into an Immunodeficient Mouse.
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Se Young JANG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Han Ik BAE
			        		
			        		;
		        		
		        		
		        		
			        		In Kyu LEE
			        		
			        		;
		        		
		        		
		        		
			        		Hwan Ki PARK
			        		
			        		;
		        		
		        		
		        		
			        		Chang Min CHO
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Case Reports ; Research Support, Non-U.S. Gov't
 - Keywords: Cholangiocarcinoma; Endoscopic ultrasound-guided fine needle aspiration; Individualized medicine; Xenograft
 - MeSH: Aged; Animals; Bile Duct Neoplasms/*pathology/surgery; Cholangiocarcinoma/*pathology/surgery; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Heterografts/*pathology/surgery; Humans; Male; Mice; Mice, Nude; Transplantation, Heterologous/*methods
 - From:Gut and Liver 2015;9(6):805-808
 - CountryRepublic of Korea
 - Language:English
 - Abstract: Patient-derived tumor xenograft is the transfer of primary human tumors directly into an immunodeficient mouse. Patient-derived tumor xenograft plays an important role in the development and evaluation of new chemotherapeutic agents. We succeeded in generating a patient-derived tumor xenograft of a biliary tumor obtained by endoscopic ultrasound-guided fine-needle aspiration from a patient who had an inoperable extrahepatic cholangiocarcinoma. This patient-derived tumor xenograft will be a promising tool for individualized cancer therapy and can be used in developing new chemotherapeutic agents for the treatment of biliary cancer in the future.
 
            